Chitogenx Stock Performance

CHNXF Stock  USD 0.01  0.00  0.00%   
ChitogenX holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.45, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ChitogenX are expected to decrease by larger amounts. On the other hand, during market turmoil, ChitogenX is expected to outperform it. Use ChitogenX coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price , to analyze future returns on ChitogenX.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ChitogenX are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, ChitogenX reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow2.4 M
Total Cashflows From Investing Activities-33 K
  

ChitogenX Relative Risk vs. Return Landscape

If you would invest  0.11  in ChitogenX on November 10, 2025 and sell it today you would earn a total of  0.65  from holding ChitogenX or generate 590.91% return on investment over 90 days. ChitogenX is currently producing 9.233% returns and takes up 73.8636% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than ChitogenX, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon ChitogenX is expected to generate 90.91 times more return on investment than the market. However, the company is 90.91 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

ChitogenX Target Price Odds to finish over Current Price

The tendency of ChitogenX OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.01 90 days 0.01 
about 18.98
Based on a normal probability distribution, the odds of ChitogenX to move above the current price in 90 days from now is about 18.98 (This ChitogenX probability density function shows the probability of ChitogenX OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon ChitogenX has a beta of -2.45 suggesting as returns on its benchmark rise, returns on holding ChitogenX are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, ChitogenX is expected to outperform its benchmark. In addition to that ChitogenX has an alpha of 9.1387, implying that it can generate a 9.14 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   ChitogenX Price Density   
       Price  

Predictive Modules for ChitogenX

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ChitogenX. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ChitogenX's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0150.39
Details
Intrinsic
Valuation
LowRealHigh
0.000.0150.39
Details

ChitogenX Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ChitogenX is not an exception. The market had few large corrections towards the ChitogenX's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ChitogenX, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ChitogenX within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
9.14
β
Beta against Dow Jones-2.45
σ
Overall volatility
0
Ir
Information ratio 0.12

ChitogenX Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ChitogenX for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ChitogenX can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ChitogenX is way too risky over 90 days horizon
ChitogenX has some characteristics of a very speculative penny stock
ChitogenX appears to be risky and price may revert if volatility continues
ChitogenX has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.92 M) with profit before overhead, payroll, taxes, and interest of 0.
ChitogenX has accumulated about 2.19 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 17.0% of the company shares are held by company insiders

ChitogenX Fundamentals Growth

ChitogenX OTC Stock prices reflect investors' perceptions of the future prospects and financial health of ChitogenX, and ChitogenX fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ChitogenX OTC Stock performance.

About ChitogenX Performance

By analyzing ChitogenX's fundamental ratios, stakeholders can gain valuable insights into ChitogenX's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ChitogenX has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ChitogenX has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada. Chitogenx is traded on OTC Exchange in the United States.

Things to note about ChitogenX performance evaluation

Checking the ongoing alerts about ChitogenX for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for ChitogenX help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ChitogenX is way too risky over 90 days horizon
ChitogenX has some characteristics of a very speculative penny stock
ChitogenX appears to be risky and price may revert if volatility continues
ChitogenX has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.92 M) with profit before overhead, payroll, taxes, and interest of 0.
ChitogenX has accumulated about 2.19 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 17.0% of the company shares are held by company insiders
Evaluating ChitogenX's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ChitogenX's otc stock performance include:
  • Analyzing ChitogenX's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ChitogenX's stock is overvalued or undervalued compared to its peers.
  • Examining ChitogenX's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ChitogenX's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ChitogenX's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of ChitogenX's otc stock. These opinions can provide insight into ChitogenX's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ChitogenX's otc stock performance is not an exact science, and many factors can impact ChitogenX's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for ChitogenX OTC Stock analysis

When running ChitogenX's price analysis, check to measure ChitogenX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChitogenX is operating at the current time. Most of ChitogenX's value examination focuses on studying past and present price action to predict the probability of ChitogenX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChitogenX's price. Additionally, you may evaluate how the addition of ChitogenX to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance